Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Daniel Beauchamp

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Oncology|June 6, 2007
Variability of in situ proteomic profiling and implications for study design in colorectal tumorsJia-Qing Li, Baogang J Xu, Bashar Shakhtour, et al.
Cancer Reports (Hoboken, N.J.)|June 11, 2021
A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancerBryan C Szeglin, Chao Wu, Michael R Marco, et al.
Oncotarget|December 20, 2017
cFLIP critically modulates apoptotic resistance in epithelial-to-mesenchymal transitionChandrasekhar Padmanabhan, Eric J Rellinger, Jing Zhu, et al.
Molecular & Cellular Proteomics : MCP|January 24, 2009
Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MSBaogang J Xu, Jiaqing Li, R Daniel Beauchamp, et al.
Oncotarget|December 7, 2017
Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastomaEric J Rellinger, Chandrasekhar Padmanabhan, Jingbo Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal CancerYufang Ma, Lihong Wang, Leif R Neitzel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancerKaren L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Gastroenterology|November 26, 2011
Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-cateninTanner J Freeman, J Joshua Smith, Xi Chen, et al.
Journal of Racial and Ethnic Health Disparities|November 15, 2014
Minority Underrepresentation in Academia: Factors Impacting Careers of Surgery ResidentsJamii St Julien, Ryan Lang, Tony N Brown, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 17, 2019
Differential Cell Susceptibilities to Kras<sup>G12D</sup> in the Setting of Obstructive Chronic PancreatitisChanjuan Shi, Fong Cheng Pan, Jessica N Kim, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Oncology|June 6, 2007
Variability of in situ proteomic profiling and implications for study design in colorectal tumorsJia-Qing Li, Baogang J Xu, Bashar Shakhtour, et al.
Cancer Reports (Hoboken, N.J.)|June 11, 2021
A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancerBryan C Szeglin, Chao Wu, Michael R Marco, et al.
Oncotarget|December 20, 2017
cFLIP critically modulates apoptotic resistance in epithelial-to-mesenchymal transitionChandrasekhar Padmanabhan, Eric J Rellinger, Jing Zhu, et al.
Molecular & Cellular Proteomics : MCP|January 24, 2009
Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MSBaogang J Xu, Jiaqing Li, R Daniel Beauchamp, et al.
Oncotarget|December 7, 2017
Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastomaEric J Rellinger, Chandrasekhar Padmanabhan, Jingbo Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal CancerYufang Ma, Lihong Wang, Leif R Neitzel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2005
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancerKaren L Tedesco, Jordan Berlin, Charles D Blanke, et al.
Gastroenterology|November 26, 2011
Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-cateninTanner J Freeman, J Joshua Smith, Xi Chen, et al.
Journal of Racial and Ethnic Health Disparities|November 15, 2014
Minority Underrepresentation in Academia: Factors Impacting Careers of Surgery ResidentsJamii St Julien, Ryan Lang, Tony N Brown, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 17, 2019
Differential Cell Susceptibilities to Kras<sup>G12D</sup> in the Setting of Obstructive Chronic PancreatitisChanjuan Shi, Fong Cheng Pan, Jessica N Kim, et al.
Pageof 8